We are live on ! Find out more
VRM

Vectors Research Management Portfolio holdings

AUM $383M
1-Year Est. Return 30.23%
This Fund
S&P 500
This Quarter Est. Return
+6.1%
1 Year Est. Return
+30.23%
3 Year Est. Return
+67.25%
5 Year Est. Return
+74.92%
10 Year Est. Return
AUM
$355M
AUM Growth
+$46.4M
Cap. Flow
+$238M
Cap. Flow %
66.98%
Top 10 Hldgs %
43.09%
Holding
142
New
18
Increased
36
Reduced
68
Closed
2

Top Buys

Rank Stock Value
1
LLY icon
Eli Lilly
LLY
+$79.1M
2
RSP icon
Invesco S&P 500 Equal Weight ETF
RSP
+$54.7M
3
MSFT icon
Microsoft
MSFT
+$48.8M
4
PG icon
Procter & Gamble
PG
+$33.4M
5
IBM icon
IBM
IBM
+$18.9M

Sector Composition

Rank Sector Weight
1 Consumer Staples 12.76%
2 Technology 9.21%
3 Healthcare 5.83%
4 Energy 4.98%
5 Industrials 4.56%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
JPM icon
26
JPMorgan Chase
JPM
$935B
$3.12M 0.88%
44,603
+25,520
+134% +$3.87M
IRM icon
27
Iron Mountain
IRM
$36.4B
$3.01M 0.85%
17,457
-35,852
-67% -$2.25M
FSLR icon
28
First Solar
FSLR
$22.7B
$2.95M 0.83%
19,720
+1,782
+10% +$273K
CVX icon
29
Chevron
CVX
$392B
$2.8M 0.79%
80,409
+60,731
+309% +$9.19M
WMB icon
30
Williams Companies
WMB
$87.5B
$2.79M 0.79%
3,468
-76,792
-96% -$2.69M
EQIX icon
31
Equinix
EQIX
$101B
$2.79M 0.79%
8,057
+4,505
+127% +$3.46M
HD icon
32
Home Depot
HD
$331B
$2.77M 0.78%
35,066
+26,944
+332% +$8.34M
CVS icon
33
CVS Health
CVS
$133B
$2.73M 0.77%
23,718
-12,371
-34% -$880K
R icon
34
Ryder
R
$9.83B
$2.64M 0.74%
52,165
+28,213
+118% +$2.97M
FLOT icon
35
iShares Floating Rate Bond ETF
FLOT
$10.2B
$2.6M 0.73%
25,001
-27,164
-52% -$1.38M
ORCL icon
36
Oracle
ORCL
$374B
$2.58M 0.73%
30,507
+5,506
+22% +$601K
RTX icon
37
RTX Corp
RTX
$290B
$2.56M 0.72%
22,031
+832
+4% +$65.8K
COP icon
38
ConocoPhillips
COP
$147B
$2.52M 0.71%
4,333
-17,631
-80% -$2.06M
LLY icon
39
Eli Lilly
LLY
$1.02T
$2.47M 0.7%
139,950
+135,535
+3,070% +$79.1M
ACN icon
40
Accenture
ACN
$102B
$2.37M 0.67%
6,775
KMI icon
41
Kinder Morgan
KMI
$71.7B
$2.37M 0.67%
6,775
-132,272
-95% -$2.25M
ALB icon
42
Albemarle
ALB
$13.9B
$2.35M 0.66%
16,308
+51
+0.3% +$7K
DUK icon
43
Duke Energy
DUK
$97.8B
$2.29M 0.64%
23,578
-792
-3% -$72K
SO icon
44
Southern Company
SO
$109B
$2.29M 0.64%
32,597
-320
-1% -$22K
DLR icon
45
Digital Realty Trust
DLR
$69.7B
$2.26M 0.64%
16,812
-353
-2% -$45.6K
ROK icon
46
Rockwell Automation
ROK
$53.4B
$2.22M 0.62%
7,142
-78
-1% -$21.9K
TJX icon
47
TJX Companies
TJX
$174B
$2.1M 0.59%
22,402
-2
-0% -$179
BKT icon
48
BlackRock Income Trust
BKT
$330M
$2.09M 0.59%
171,358
-16,947
-9% -$194K
GWW icon
49
W.W. Grainger
GWW
$65.3B
$2.09M 0.59%
2,519
-16
-0.6% -$12.3K
SPIB icon
50
State Street SPDR Portfolio Intermediate Term Corporate Bond ETF
SPIB
$11.5B
$2.07M 0.58%
63,004
-32,635
-34% -$1.04M

Similar funds

Vectors Research Management's Q4 2023 Portfolio in Review

As of Q4 2023, Vectors Research Management held 142 positions worth $355M, up 15% from $309M the previous quarter. Its ten largest holdings account for 43% of the portfolio.

Vectors Research Management deployed $238M of net new capital in Q4 2023, opening 18 new positions and adding to 36 existing holdings. Its largest new stake was iShares Core S&P Small-Cap ETF: 78,869 shares worth $5M.

By sector, the portfolio is most concentrated in Consumer Staples at 13% of assets, up from 3% a quarter earlier, followed by Technology and Healthcare.

On the sell side, the largest reduction was Invesco Variable Rate Investment Grade ETF, an estimated $12.9M trimmed.

  • Vectors Research Management's largest Q4 2023 buy was iShares Core S&P Small-Cap ETF: 78,869 shares worth $5M.
  • Vectors Research Management added most to Eli Lilly in Q4 2023, an estimated $79.1M increase.
  • Vectors Research Management's biggest Q4 2023 reduction was Invesco Variable Rate Investment Grade ETF, cutting an estimated $12.9M.
  • Vectors Research Management fully exited Best Buy in Q4 2023, selling an estimated $654K.
  • Vectors Research Management's ten largest holdings make up 43% of its $355M portfolio in Q4 2023.
  • Vectors Research Management opened 18 new positions and closed 2 in Q4 2023.
  • Vectors Research Management's portfolio value rose 15% quarter-over-quarter to $355M.

Based on Vectors Research Management's 13F filing for Q4 2023, filed 12 Feb 2024.